The medium-term outlook is for further consolidation and contraction of compounding supply of peptides, as pharmacies assess legal risk
Delhanty PJ, Sun Y, Visser JA, van Kerkwijk A, Huisman M, van Ijcken WF, et al
The class-level FDA-labeled side-effect profile (nausea, GI symptoms, less-common pancreatitis and gallbladder events, boxed warning for thyroid C-cell tumors based on rodent studies) applies to both compounded and branded versions of the same active ingredients
SS-31 targets mitochondrial function, supporting cellular energy production that underlies all regenerative processes
They dont have an Ordering and Shipping section on their site and have limited information about any of this